Thus, these data suggest that TMOC does have a cytotoxic effect on ovarian tumor cells regardless p53 status, but processes less cytotoxicity in pre-neoplastic ovarian epithelial cells. This evidence concerns the gene TP53 and ovarian neoplasm.